glp 1 affirm TrimRX GLP-1

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

This specialized delivery system helps shield the active berberine molecules through the stomach, supporting up to 10X greater cellular uptake while remaining gentle on your digestive system

GLP-1-S is a synthetic research peptide studied in laboratory settings for its interaction with GLP-1 receptor signaling pathways, metabolic regulation models, and neuroendocrine communication research

By exploring human studies and mechanistic insights, this review underscores irisins potential to address global health challenges, such as obesity and type 2 diabetes, while advancing strategies for personalized exercise interventions.

Glucagon-like peptide-1 (GLP-1) is one of the incretins that regulate glucose metabolism